That doesnt mean consumers will stop seeking comfort, pleasure or emotional connection through food
The regulation of GSH/GPX4-mediated lipid accumulation confirms that schisandra polysaccharides should be valued equally as lignans
Its virile effect was discovered accidentally during an experiment by Mac Hadley
A person with lupus might be more likely to benefit from discussing a GLP-1 medicine with their clinician if they have: Type 2 diabetes Obesity or overweight with weight-related health problems High blood pressure High cholesterol Fatty liver disease High cardiovascular risk Kidney risk factors Difficulty losing weight despite serious lifestyle efforts These medicines may be especially worth discussing when weight, diabetes, or cardiovascular risk is making lupus care more difficult
Sources: HMA survey KFF Employer Benefit survey CVS earnings call transcript Medicare GLP-1 Bridge Business Group on Health survey Repost to share GLP-1 coverage expansion data Follow me for more on pharmacy benefits trends (Bryce Platt, PharmD) Coverage is expanding, but this feels less like a yes/no decision and more like a shift toward tighter control
GLP-1 users are starting to feel the effects of stricter FDA rules for compounded semaglutide production
